- Investing Ideas
- /
- U.S. Financially Fit Penny Stocks
U.S. Financially Fit Penny Stocks
Results
724
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
724 companies
Zenvia
Market Cap: US$70.0m
Develops a cloud-based platform that enables organizations to integrate several communication capabilities in Brazil, the United States, Argentina, Mexico, Netherlands, Malta, Peru, Switzerland, Colombia, Chile, and internationally.
ZENV
US$1.35
7D
-21.1%
1Y
-64.9%
Veru
Market Cap: US$76.2m
A late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS).
VERU
US$0.52
7D
-0.3%
1Y
-63.4%
Ikena Oncology
Market Cap: US$53.6m
An oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance.
IKNA
US$1.11
7D
-2.6%
1Y
-20.7%
Research Solutions
Market Cap: US$89.7m
Through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally.
RSSS
US$2.96
7D
-2.3%
1Y
3.5%
Black Diamond Therapeutics
Market Cap: US$110.9m
A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.
BDTX
US$1.95
7D
11.4%
1Y
-60.2%
PetMed Express
Market Cap: US$79.6m
Operates as a pet pharmacy in the United States.
PETS
US$3.86
7D
3.8%
1Y
-16.5%
Braemar Hotels & Resorts
Market Cap: US$157.5m
Together with its subsidiaries (“Braemar”), is a Maryland corporation that invests primarily in high revenue per available room (“RevPAR”) luxury hotels and resorts.
BHR
US$2.13
7D
0.5%
1Y
-23.9%
Aftermath Silver
Market Cap: US$98.5m
An exploration stage company, acquires, explores, and develops mineral properties in Chile and Peru.
AAGF.F
US$0.33
7D
-2.9%
1Y
3.4%
MAIA Biotechnology
Market Cap: US$54.6m
MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer.
MAIA
US$1.80
7D
-6.3%
1Y
-47.2%
Mentor Capital
Market Cap: US$915.6k
A private equity firm specializing in acquisitions and emerging growth investments.
MNTR
US$0.042
7D
-4.0%
1Y
-15.6%
LiqTech International
Market Cap: US$14.6m
A clean technology company, engages in the development, design, production, marketing, and sale of automated filtering systems, ceramic silicon carbide liquid applications, and diesel particulate air filters in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa.
LIQT
US$1.52
7D
5.9%
1Y
-44.7%
Immatics
Market Cap: US$576.1m
A clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States.
IMTX
US$4.74
7D
3.9%
1Y
-56.7%
BTC Digital
Market Cap: US$25.9m
A crypto asset technology company engages in bitcoin mining business.
BTCT
US$4.03
7D
-5.6%
1Y
77.6%
Alto Neuroscience
Market Cap: US$68.5m
Operates as a clinical-stage biopharmaceutical company in the United States.
ANRO
US$2.53
7D
8.1%
1Y
-79.6%
Pyxis Oncology
Market Cap: US$75.0m
A clinical stage company, engages in the development of therapeutics to treat solid tumors.
PYXS
US$1.21
7D
5.2%
1Y
-71.1%
Ascent Solar Technologies
Market Cap: US$2.9m
A solar technology company, engages in the manufacture and sale of photovoltaic solar modules in the United States.
ASTI
US$1.71
7D
-14.5%
1Y
-85.8%
Quanterix
Market Cap: US$186.0m
A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
QTRX
US$4.79
7D
-16.4%
1Y
-72.2%
Agora
Market Cap: US$327.3m
Engages in the operation of a real-time engagement platform-as-a-service in the United States, the People’s Republic of China, and internationally.
API
US$3.50
7D
-2.0%
1Y
22.0%
Cambium Networks
Market Cap: US$13.3m
Engages in the design, development, and manufacture of wireless broadband and Wi-Fi networking infrastructure solutions.
CMBM
US$0.47
7D
-0.8%
1Y
-86.9%
Gaia
Market Cap: US$107.8m
Operates a digital video subscription service and online community for underserved member base in the United States, Canada, Australia, and internationally.
GAIA
US$4.31
7D
-9.3%
1Y
-1.4%
MediciNova
Market Cap: US$64.7m
A biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.
MNOV
US$1.32
7D
-8.3%
1Y
-3.6%
Incannex Healthcare
Market Cap: US$7.2m
A clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia.
IXHL
US$0.26
7D
205.9%
1Y
-89.8%
Flora Growth
Market Cap: US$13.1m
Engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide.
FLGC
US$0.68
7D
-9.9%
1Y
-45.1%
Apyx Medical
Market Cap: US$54.0m
An energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally.
APYX
US$1.43
7D
29.4%
1Y
-10.6%
Haoxi Health Technology
Market Cap: US$4.0m
Through its subsidiaries, provides online marketing solutions in China.
HAO
US$1.40
7D
-13.6%
1Y
-99.1%
CN Energy Group
Market Cap: US$35.6m
Through its subsidiaries, manufactures and supplies wood-based activated carbon in China.
CNEY
US$2.92
7D
-39.4%
1Y
-82.4%
Jianpu Technology
Market Cap: US$46.4m
Operates an open financial technology platform under the Rong360 brand primarily in the People’s Republic of China.
AIJT.Y
US$2.49
7D
3.8%
1Y
344.6%
Adverum Biotechnologies
Market Cap: US$44.2m
A clinical-stage company, develops gene therapy product candidates to treat ocular diseases.
ADVM
US$2.12
7D
-22.0%
1Y
-74.4%
Beam Global
Market Cap: US$26.3m
A clean-technology innovation company, engages in the design, development, engineering, manufacture, and sale of renewably energized infrastructure products and battery solutions in the United States and Romania.
BEEM
US$1.70
7D
-9.6%
1Y
-73.8%
Equillium
Market Cap: US$13.4m
A clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States.
EQ
US$0.37
7D
-2.6%
1Y
-75.9%
VYNE Therapeutics
Market Cap: US$19.5m
A clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions.
VYNE
US$1.22
7D
-2.4%
1Y
-55.3%
PMV Pharmaceuticals
Market Cap: US$45.0m
A precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer.
PMVP
US$0.87
7D
0.2%
1Y
-60.8%
Inuvo
Market Cap: US$66.5m
An advertising technology and services company, develops and commercializes large language generative artificial intelligence that discovers and targets digital audiences in the United States.
INUV
US$0.46
7D
14.5%
1Y
53.6%
Vir Biotechnology
Market Cap: US$635.9m
A clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.
VIR
US$4.60
7D
-13.2%
1Y
-52.5%
NextPlat
Market Cap: US$15.1m
Operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa.
NXPL
US$0.58
7D
-1.7%
1Y
-51.7%
Clover Health Investments
Market Cap: US$1.8b
Provides medicare advantage plans in the United States.
CLOV
US$3.55
7D
2.3%
1Y
296.4%